Society guideline links: Urticaria and angioedema (excluding hereditary angioedema)

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Hereditary angioedema and other forms of nonhistaminergic angioedema".)

International

●European Academy of Allergy and Clinical Immunology (EAACI)/Global Allergy and Asthma European Network (GA2LEN)/European Centre for Guidelines Development (EuroGuiDerm)/Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAAACI): The international guideline for the definition, classification, diagnosis, and management of urticaria (2022)

●World Allergy Organization (WAO): Management of chronic spontaneous urticaria – A worldwide perspective (2018)

●WAO: Diagnosis and treatment of urticaria and angioedema – A worldwide perspective (2012)

United States

●Joint Task Force on Practice Parameters (JTFPP): Practice parameter on the diagnosis and management of acute and chronic urticaria, update (2014)

Europe

●European Academy of Allergy and Clinical Immunology (EAACI): Position paper – Evidence for autoimmune urticaria and proposal for defining diagnostic criteria (2012)

United Kingdom

●British Association of Dermatologists (BAD): Guidelines for the management of people with chronic urticaria (2021)

●British Society for Allergy and Clinical Immunology (BSACI): Guideline for the management of chronic urticaria and angioedema (2015)

●Royal College of Paediatrics and Child Health (RCPCH): Allergy care pathways for children – Urtricaria/angio-oedema/mastocytosis (2011)

Australia–New Zealand

●Choosing Wisely Australia: Acute urticaria (ie, of less than 6 weeks duration) does not routinely require investigation for an underlying cause. Where clinical history and examination suggest the possibility of a bacterial infection or food as a likely trigger, further testing may be warranted. If individual lesions (weals) persist for longer than 24 hours an alternative diagnosis may need to be considered (2021)

●Australasian Society of Clinical Immunology and Allergy (ASCIA): Position paper on chronic spontaneous urticaria (CSU) (2020)

Japan

●[In Japanese] Japanese Dermatological Association (JDA): Urticaria clinical practice guideline (2018)

●[In English] JDA: Japanese guidelines for diagnosis and treatment of urticaria in comparison with other countries (2012)